研究简报

一种构建吡喃并[2,3-d]嘧啶酮衍生物的简易方法

  • 林志兰 ,
  • 张俊民 ,
  • 高原
展开
  • 深圳大学化学与环境工程学院 深圳 518060

收稿日期: 2015-09-28

  修回日期: 2015-10-26

  网络出版日期: 2015-11-06

基金资助

国家自然科学基金(No. 21402124)资助项目.

A Convenient Method to Prepare Pyrano[2,3-d]pyrimidine Derivatives

  • Lin Zhilan ,
  • Zhang Junmin ,
  • Gao Yuan
Expand
  • College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060

Received date: 2015-09-28

  Revised date: 2015-10-26

  Online published: 2015-11-06

Supported by

Project supported by the National Natural Science Foundation of China (No. 21402124).

摘要

在浓硫酸催化下, 2-氨基-3-氰基-4H-吡喃类化合物与乙酸酐反应, 较高产率地合成了一系列吡喃并[2,3-d]嘧啶酮衍生物. 该方法反应时间短(10~15 min)、操作简单、后处理方便. 所合成产物的结构经红外光谱、核磁共振谱表征确证, 其中化合物4a6a的结构还通过X 射线单晶衍射分析确认.

本文引用格式

林志兰 , 张俊民 , 高原 . 一种构建吡喃并[2,3-d]嘧啶酮衍生物的简易方法[J]. 有机化学, 2016 , 36(3) : 659 -663 . DOI: 10.6023/cjoc201509037

Abstract

A series of pyrano[2,3-d]pyrimidine derivatives were synthesized by the reaction of 2-amino-3-cyano-4H-pyrans with acetic anhydride. This method has the advantages of short reaction times (10~15 min), simple operation and convenient post-treatment. All products were fully characterized by IR and 1H NMR spectra. The molecular structures of 4a and 6a were confirmed using single-crystal X-ray analyses.

参考文献

[1] Sasaki, S.; Cho, N.; Nara, Y.; Harada, M.; Endo, S.; Suzuki, N.; Furuya, S.; Fujino, M. J. Med. Chem. 2003, 46, 113.
[2] Rashad, A. E.; Shamroukh, A. H.; Abdel-Megeid, R. E.; El-Sayed, W. A. Synth. Commun. 2010, 40, 1149.
[3] Castro, A.; Jerez, M. J.; Gil, C.; Calderon, F.; Doménech, T.; Nueda, A.; Martnez, A. Eur. J. Med. Chem. 2008, 43, 1349.
[4] Carpenter, A. J.; Al-Barazanji, K. A.; Barvian,K. K.; Bishop, M. J.; Britt, C. S.; Cooper, J. P.; Goetz, A. S.; Grizzle, M. K.; Hertzog, D. L.; Ignr, D. M.; Morgan, R. O.; Peckham, G. E.; Speake, J. D.; Swain, W. R. Bioorg. Med. Chem. Lett. 2006, 16, 4994.
[5] Li, L. H.; Wallace, T. L.; Richard, K. A.; Tracey, D. E. Cancer Res. 1985, 45, 532.
[6] Bartolini, S.; Mai, A.; Artico, M.; Paesano, N.; Rotili, D.; Spadafora, C.; Sbardella, G. J. Med. Chem. 2005, 48, 6776.
[7] Clark, J. H.; Miller, J. M. J. Am. Chem. Soc. 1977, 99, 498.
[8] Nishigaki, S.; Ogiwara, K.; Fukazawa, S.; Ichiba, M.; Mizushima, N.; Yoneda, F. J. Med. Chem. 1972, 15, 731.
[9] Saravanan, K.; Barlow, H. C.; Barton, M.; Calvert, A. H.; Golding, B. T.; Newell, D. R.; Northen, J. S.; Curtin, N. J.; Thomas, H. D.; Griffin, R. J. J. Med. Chem. 2011, 54, 1847.
[10] (a) Grivsky, E. M.; Lee, S.; Sigel, C. W.; Duch, D. S.; Nichol, C. A. J. Med. Chem. 1980, 23, 327.
(b) Davoll, J.; Clarke, J.; Elslager, E. F. J. Med. Chem. 1972, 15, 837.
[11] Mohamed, F. K,; Essawy, A. I.; Soliman, A. Y.; Badrey, M. G. Pharm. Chem. 2009, 1, 1.
[12] McCoy, J. G.; Marugan, J. J.; Liu, K.; Zheng, W.; Southall, N.; Huang, W.; Heilig, M.; Austin, C. P. ACS Chem. Neurosci. 2010, 1, 559.
[13] (a) Azzam, S. H. S.; Pasha, M. A. Tetrahedron Lett. 2012, 53, 7056.
(b) Younes, S. H. H.; Mohamed, S. K.; Albayati, M. R. Arch. Pharm. Chem. Life Sci. 2013, 346, 727.
(c) Veisi, H.; Maleki, A.; Omrani, Z.; Lotfi, S. RSC Adv. 2014, 4, 55313.
(d) Maddila, S. N.; Maddila, S.; Zyl, W. E.; Jonnalagadda, S. B. RSC Adv. 2015, 5, 37360.
(e) Li, S.-H.; Gao, N.; Li, J.-T. Chin. J. Org. Chem. 2009, 29, 466 (in Chinese). (李胜辉, 高娜, 李记太, 有机化学, 2009, 29, 466.)
[14] Lin, Z.-L.; Zhang, X.-L.; You, X.-K.; Gao, Y. Tetrahedron 2012, 68, 6759.
[15] (a) Zhang, X.-L.; Huang, Y.; Li, Z.-N.; Lu, Y.-J.; Gao, Y. Chin. J. Org. Chem. 2006, 26, 1434 (in Chinese). (张雪利, 黄毅, 李卓宁, 吕玉娟, 高原, 有机化学, 2006, 26, 1434.)
(b) Tu, S.-J.; Jiang, H.; Zhuang, Q.-Y.; Miao, C.-B.; Shi, D.-Q.; Wang, X.-S.; Gao, Y. Chin. J. Org. Chem. 2003, 23, 488 (in Chinese). (屠树江, 蒋虹, 庄启亚, 缪春宝, 史达清, 王香善, 高原, 有机化学, 2003, 23, 488.)

文章导航

/